#Onward Medical
2 articles with this tag
Onward Medical Q3 2025: Earnings Presentation Highlights Operational and R&D Progress
Onward Medical's Q3 2025 presentation highlighted clinical progress, manufacturing and regulatory workstreams, and management's focus on capital discipline as programs advance toward commercializat...
Seeking Alpha
2 min read
Stocks
Market Analysis
Biotechnology
Onward Medical Q3 2025 Earnings Call: Clinical Progress and Commercial Plans
Onward Medical's Q3 2025 call highlighted clinical enrollment, commercialization readiness, manufacturing scale-up and focused R&D spending as the company advances spinal cord therapies.
Seeking Alpha
2 min read
Stocks
Biotechnology
Medical Devices